← SynDRA
FENOFIBRATE
SynDRA canonical compound SYN0001343 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | PPARA |
|---|
| Mechanism of action | PPAR receptor agonist |
|---|
| Indication | hypercholesterolemia | hypertriglyceridemia |
|---|
| Disease area | endocrinology |
|---|
All known targets
- PPARA
- ABCG2
- ACHE
- ADORA3
- ADRB3
- APOA1
- CYP2C19
- CYP2C8
- DRD3
- Fabp1
- HTR2A
- HTR2C
Mechanisms of action (all sources)
- PPAR receptor agonist
- PPARA AGONIST
- Peroxisome proliferator-activated receptor alpha agonist
Drug classes
- Peroxisome Proliferator-activated Receptor alpha Agonists
- Antimetabolites
- Hypolipidemic Agents
- Lipid Regulating Agents
- Peroxisome Proliferator Receptor alpha Agonist
ATC classes
- C10A · LIPID MODIFYING AGENTS, PLAIN
- LIPID MODIFYING AGENTS, COMBINATIONS
Cross-references
Synonyms
- clorofibrate
- fenobrate
- lipofene
- procetofen
- procetofene
- Fenofibrato
- Fenofibrate delayed release
- Fenofibrate micronized
- NSC-281319
- Antara
- Antara (micronized)
- Fenofibrate (micronized)
- Fenogal
- Fenoglide
- Lipantil
- Lipantil micro 200
- Lipantil micro 267
- Lipantil micro 67
- Lipidil
- Lipofen
- Supralip 160
- Tricor
- Tricor (micronized)
- Triglide
- Ankebin
- Controlip
- Durafenat
- Elasterate
- Elasterin
- FNF
- Fenobeta
- Fenobrate
- Fenofanton
- Fenofibratum
- Fenomax
- Fenotard
- Finofibrate
- Fulcro
Reported adverse events
- Constipation
- Rhinitis
- Cholelithiasis
- Hypersensitivity
- Myopathy
- Pancreatitis
- Photosensitivity reaction
- Urticaria
- Headache
- Nausea
- Rhabdomyolysis
- Hepatotoxicity
Look up FENOFIBRATE in the interactive SynDRA portal →